Search Results - "Menasherov, Nikolai"

Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma by Solomon, Daniel, Abbas, Muhammad, Feferman, Yael, Haddad, Riad, Perl, Gali, Kundel, Yulia, Morgenstern, Sara, Menasherov, Nikolai, Kashtan, Hanoch

“…Background While the prognosis of patients with locoregional esophageal adenocarcinoma (EAC) has improved in the neoadjuvant treatment (NAT) era, high-grade…”
Get full text

Gastrectomy for Distal Gastric Cancer: Transitioning from an Open to a Minimally Invasive Surgical Practice. A Single Surgeon Experience by Solomon, Daniel, Greemland, Itzhak, Menasherov, Nikolai, Bard, Vyacheslav

“…Surgical resection is the only curative option for gastric carcinoma (GC). Minimally invasive techniques are gaining popularity. To present a single-surgeon's…”
Get full text

Cardiac Tamponade: A Rare and Insidious Surgical Complication of Hiatal Hernia Repair by Apel, Roy, Bard, Slava, Naimark, Ari, Menasherov, Nikolai, Wasserberg, Nir, Wiesel, Ory

Get full text

Thoracic Duct Visualization in Esophageal Resection: A Pilot Trial by Berger, Yael, Bard, Vyacheslav, Abbas, Muhammad, Solomon, Daniel, Menasherov, Nikolai, Kashtan, Hanoch

“…Inadvertent thoracic duct injury is common during esophagectomy and may result in postoperative chylothorax. This study's objective was to investigate utility…”
Get more information

Implementing the first program of minimally invasive esophagectomy for cancer in Israel: shifting the paradigm in a high-volume center. a cohort study by Solomon, Daniel, Sarfaty, Elad, Menasherov, Nikolai, Bard, Vyacheslav, Bueno, Raphael, Kashtan, Hanoch

“…Background: Esophagectomy is associated with significant perioperative morbidity. Limited data are available on the process of implementation of minimally…”
Get full text

Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer by Wiesel, Ory, Zlotnik, Oran, Morgenstern, Sarah, Tsur, Maya, Menasherov, Nikolai, Feferman, Yael, Ben-Aharon, Irit, Kashtan, Hanoch

“…Favorable pathologic response(FPR) is a significant predictor for improved survival following Neoadjuvant therapy(NAT) in esophageal and gastroesophageal…”
Get full text

Long‐term outcomes after esophagectomy for end‐stage achalasia: A bridge to a better quality of life? by Bard, Vyacheslav, Solomon, Daniel, Raveh, Guy, Menasherov, Nikolai, Kashtan, Hanoch

“…Objective We sought to evaluate the outcomes of patients with end‐stage achalasia (ESA) who underwent esophagectomy. Methods All patients who underwent…”
Get full text

Proteomic analysis to identify markers for response to treatment in esophageal cancer by Zlotnik, Oran, Goshen-Lago, Tal, Brenner, Baruch, Kundel, Yulia, Menasherov, Nikolai, Kashtan, Hanoch, Ben-Aharon, Irit

“…Abstract only 61 Background: Neoadjuvant chemoradiotherapy (NCRT) followed by surgery represents a key therapeutic strategy for locally advanced esophageal…”
Get full text

The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial by Brenner, Baruch, Purim, Ofer, Gordon, Noa, Goshen – Lago, Tal, Idelevich, Efraim, Kashtan, Hanoch, Menasherov, Nikolai, Fenig, Eyal, Sulkes, Aaron, Kundel, Yulia

“…•This phase IB/II study evaluated the safety and efficacy of the addition of cetuximab to standard preoperative CRT in LAEC.•The addition of cetuximab to…”
Get full text

Gastrointestinal Stromal Tumor of Stomach: A Gentle Enemy of the Surgeon. Our Experience in Confronting the Disease by Bard, Vyacheslav, Menasherov, Nikolai, Morgenstern, Sara, Haddad, Riad, Kashtan, Hanoch

“…BACKGROUND:Surgical resection is considered to be the best treatment for gastrointestinal stromal tumor (GIST), the most common mesenchymal tumor of the…”
Get full text

Tu1599 Surgery for Early Esophageal Cancer: Operative Outcome and Long-Term Survival by Bard, Vyacheslav, Stein, Michael, Menasherov, Nikolai, Kashtan, Hanoch

Get full text

Abdominal Surgery in Patients with a Ventricular Assist Device: A Single Center Experience in Israel by Zilbermints, Veacheslav, Israeli, Oren, Ben Abraham, Binyamin, Ben-Gal, Tuvia, Rubchevsky, Victor, Aravot, Dan, Kashtan, Hanoch, Menasherov, Nikolai, Aranovich, David

“…BACKGROUNDLeft ventricular assist devices (LVADs) are used more commonly in patients with advanced-stage heart failure. Some of these patients may require…”
Get full text

Esophageal cancer in Israel: A unique clinicopathological entity? by Sarfaty, Michal, Purim, Ofer, Kundel, Yulia, Ulitsky, Olga, Menasherov, Nikolai, Kashtan, Hanoch, Sulkes, Aaron, Brenner, Baruch

“…Abstract only…”
Get full text

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using 18 F-FDG PET-CT imaging: a prospective cohort study by Brenner, Baruch, Kundel, Yulia, Cohen, Zoya, Brand, Hadar, Gordon, Noa, Sulkes, Aaron, Morgenstern, Sara, Menasherov, Nikolai, Kashtan, Hanoch, Groshar, David, Domachevsky, Liran, Bernstine, Hanna

“…Previous studies in locally advanced esophageal cancer (LAEC) suggested that a change in the tumor's metabolic response, i.e., decrease of its interim F-FDG…”
Get full text

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using 18F-FDG PET-CT imaging: a prospective cohort study by Brenner, Baruch, Kundel, Yulia, Cohen, Zoya, Brand, Hadar, Gordon, Noa, Sulkes, Aaron, Morgenstern, Sara, Menasherov, Nikolai, Kashtan, Hanoch, Groshar, David, Domachevsky, Liran, Bernstine, Hanna

“…BackgroundPrevious studies in locally advanced esophageal cancer (LAEC) suggested that a change in the tumor's metabolic response, i.e., decrease of its…”
Get full text

Association of the addition of cetuximab to preoperative chemoradiotherapy (CRT) for locally advanced esophageal squamous cell carcinoma (SqCC) with rate of long term survival: Mature results of a prospective phase Ib/II trial by Brenner, Baruch, Purim, Ofer, Gordon, Noa, Goshen Lago, Tal, Idelevich, Efraim, Kashtan, Hanoch, Menasherov, Nikolai, Fenig, Eyal, Sulkes, Aaron, Kundel, Yulia

“…Abstract only 4057 Background: Current treatment results in locally advanced esophageal cancer (LAEC) are far from being satisfying. This prospective phase…”
Get full text

Preoperative chemoradiation and cetuximab for resectable, locally advanced esophageal cancer: Preliminary results of a prospective phase Ib/II trial by Brenner, Baruch, Kundel, Yulia, Purim, Ofer, Medalia, Gal, Olshinka, Liran, Kashtan, Hanoch, Menasherov, Nikolai, Fenig, Eyal, Sulkes, Aaron, Idelevich, Efraim

“…Abstract only e14571 Background: This prospective phase IB/II study evaluated the safety and efficacy of the addition of cetuximab to standard preoperative…”
Get full text

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study by Sarfaty, Michal, Lankry, Esty, Moore, Assaf, Kurman, Noga, Purim, Ofer, Kundel, Yulia, Ben-Aharon, Irit, Perl, Gali, Ulitsky, Olga, Gordon, Noa, Sulkes, Aaron, Menasherov, Nikolai, Kashtan, Hanoch, Brenner, Baruch

“…Data regarding esophageal cancer (EC) in Israel are limited. The aim of this study was hence to characterize this entity in the Israeli population and to…”
Get full text